Treatment of Acne in Teenagers

First-Line Treatment

The American Academy of Dermatology recommends adapalene 0.1% gel combined with benzoyl peroxide 2.5-5% as the foundation for treating acne in teenagers, as this combination addresses comedones, inflammation, and prevents bacterial resistance 1, 2, 3
Adapalene 0.1% is FDA-approved for patients ≥9 years and available over-the-counter, making it highly accessible for teenagers with acne 1, 3
Starting with benzoyl peroxide 2.5% concentration is recommended to minimize irritation, as lower concentrations are equally effective with better tolerability 1, 3
Applying adapalene as a thin layer to the entire affected area once daily in the evening after gentle cleansing is the recommended application instructions 1, 3

The American Academy of Dermatology suggests adding clindamycin 1% or erythromycin 3% combined with benzoyl peroxide if inflammatory lesions persist, with a strength of evidence rated as moderate 1, 2, 3, 4
Fixed-dose combination products, such as clindamycin 1%/benzoyl peroxide 5% or erythromycin 3%/benzoyl peroxide 5%, enhance compliance and are recommended for teenagers with acne 2, 4
Topical antibiotics should never be used as monotherapy, as this rapidly causes bacterial resistance, with a high strength of evidence supporting this recommendation 1, 2, 3
For moderate-to-severe acne with significant inflammatory lesions, adding doxycycline 100 mg once daily to the topical regimen is recommended, with a strength of evidence rated as strong 1, 2
Doxycycline is strongly recommended for patients ≥9 years with moderate evidence, but its use in children under 8 years is contraindicated due to the risk of permanent tooth discoloration 1, 2, 3

Referral to dermatology for consideration of isotretinoin is recommended if there is no improvement after 8-12 weeks of appropriate therapy, or if evidence of scarring, severe nodular or cystic acne, or significant psychological impact is present, with a strength of evidence rated as high 1, 2, 3
Isotretinoin is indicated for severe nodular acne, treatment-resistant moderate acne, or any acne with scarring or significant psychosocial burden, with a standard dosing of 0.5-1.0 mg/kg/day targeting a cumulative dose of 120-150 mg/kg 2
For female patients, combined oral contraceptives reduce inflammatory lesions by 62% at 6 months and are conditionally recommended for inflammatory acne, while spironolactone 25-200 mg daily is useful for hormonal acne patterns or premenstrual flares, with a strength of evidence rated as moderate 2

Delaying treatment can lead to scarring, which is a primary concern for teenagers with acne, with a high strength of evidence supporting early aggressive therapy 1, 2, 3
Using antibiotics without concurrent benzoyl peroxide can lead to resistance, with a high strength of evidence supporting the use of combination therapy 1, 2, 3
Applying retinoids to broken skin or active eczema can increase irritation, with a moderate strength of evidence supporting cautious use 1
Extending oral antibiotics beyond 3-4 months without re-evaluation can increase resistance risk, with a high strength of evidence supporting limited use 1, 2

Common side effects of acne treatment include erythema, scaling, dryness, and stinging/burning, with a moderate strength of evidence supporting the use of moisturizers to minimize irritation 1, 3, 4
Starting with lower concentrations and less frequent application, then gradually increasing as tolerated, can help minimize side effects, with a moderate strength of evidence supporting this approach 1, 3

Assessing response at 4-6 weeks and re-evaluating at 6-8 weeks for efficacy is recommended, with a moderate strength of evidence supporting regular follow-up 1, 3
If no improvement is seen after 8-12 weeks, escalating therapy or referring to dermatology is recommended, with a high strength of evidence supporting this approach 1, 3
Once clearance is achieved, continuing topical retinoid (adapalene) indefinitely for maintenance can help prevent recurrence, with a moderate strength of evidence supporting long-term use 1, 2